Percutaneous transluminal therapeutic ultrasound for high‐risk thrombus‐containing lesions in native coronary arteries

We assessed the short‐term outcome of percutaneous coronary ultrasound thrombolysis (CUT) for high‐risk thrombus‐containing lesions in native coronaries in the setting of acute coronary syndromes (ACS). Data were prospectively collected in a multicenter (n = 32) registry of consecutive ACS patients. The study population (n = 126) had mostly (84%) totally occluded vessels. The mean age of clot was 5.7 ± 9.5 days (range, 0–60 days). CUT (41 kHz, 18 W) led to device success in 112 (89%) patients, with a residual stenosis of 69% ± 20%. Adjunct PTCA or stenting was used in 97% of the patients. Procedural success was achieved in 124 (98%) patients, with a final residual stenosis of 6% ± 10%. There were no major adverse clinical events during hospitalization. Ultrasound thrombolysis is a feasible procedure that offers a safe and probably effective adjuvant device solution for the treatment of high‐risk, thrombus‐containing lesions in the native coronary arteries. Cathet Cardiovasc Intervent 2002;55:43–49. © 2002 Wiley‐Liss, Inc.

[1]  V. Fuster,et al.  Coronary artery disease: pathogenesis and acute coronary syndromes. , 2001, The Mount Sinai journal of medicine, New York.

[2]  Bruce R. Brodie,et al.  Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction , 1999 .

[3]  David P Miller,et al.  Relation between lesion characteristics and risk with percutaneous intervention in the stent and glycoprotein IIb/IIIa era: An analysis of results from 10,907 lesions and proposal for new classification scheme. , 1999, Circulation.

[4]  M. Simoons,et al.  Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trial. , 1999, European heart journal.

[5]  S. Snapinn,et al.  Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and s , 1999, Circulation.

[6]  T. McCaffrey,et al.  Novel distal occluder washout method for prevention of no‐reflow during stenting of saphenous vein grafts , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[7]  R. Erbel,et al.  Percutaneous transluminal therapy of occluded saphenous vein grafts: can the challenge be met with ultrasound thrombolysis? , 1999, Circulation.

[8]  R. Califf,et al.  Does Intracoronary Thrombus Influence the Outcome of High Risk Percutaneous Transluminal Coronary Angioplasty? Clinical and Angiographic Outcomes in a Large Multicenter Trial fn1fn1This study was suppported by a grant from Centocor, Inc. , 1998 .

[9]  U. Rosenschein,et al.  Analysis of coronary ultrasound thrombolysis endpoints in acute myocardial infarction (ACUTE trial). Results of the feasibility phase. , 1997, Circulation.

[10]  C. Macaya,et al.  Clinical and angiographic implications of coronary stenting in thrombus-containing lesions. , 1997, Journal of the American College of Cardiology.

[11]  S Wallenstein,et al.  Correlation of angiographic morphology and clinical presentation in unstable angina. , 1997, Journal of the American College of Cardiology.

[12]  E. Topol,et al.  Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. , 1996, Circulation.

[13]  P. Teirstein,et al.  Coronary thrombi increase PTCA risk. Angioscopy as a clinical tool. , 1996, Circulation.

[14]  C. White,et al.  Coronary angioscopy of abrupt occlusion after angioplasty. , 1995, Journal of the American College of Cardiology.

[15]  S. Laniado,et al.  Study of the mechanism of ultrasound angioplasty from human thrombi and bovine aorta. , 1994, The American journal of cardiology.

[16]  Epic Investigators,et al.  Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. , 1994, The New England journal of medicine.

[17]  E. Topol,et al.  Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator Group. , 1994, Circulation.

[18]  K. Bailey,et al.  Coronary embolization after balloon angioplasty or thrombolytic therapy: an autopsy study of 32 cases. , 1993, Journal of the American College of Cardiology.

[19]  E. Topol,et al.  Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. , 1992, Journal of the American College of Cardiology.

[20]  K. Mizuno,et al.  Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. , 1992, The New England journal of medicine.

[21]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (1). , 1992, The New England journal of medicine.

[22]  B Meier,et al.  Angiographic follow-up after placement of a self-expanding coronary-artery stent. , 1991, The New England journal of medicine.

[23]  L. Becker,et al.  Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography. , 1990, Journal of the American College of Cardiology.

[24]  C. Simpfendorfer,et al.  Role of intracoronary thrombus in acute complications during percutaneous transluminal coronary angioplasty. , 1989, Catheterization and cardiovascular diagnosis.

[25]  T. P. Judge,et al.  Coronary arteriographic findings soon after non-Q-wave myocardial infarction. , 1986, The New England journal of medicine.

[26]  V. Fuster,et al.  Angiographic evolution of coronary artery morphology in unstable angina. , 1986, Journal of the American College of Cardiology.